HEALTH

GlaxoSmithKline wins recommendation to sell Alli in Europe

BY Michael Johnsen

LONDON GlaxoSmithKline won a recommendation from European regulators Thursday that it be allowed to sell its weight loss drug Alli over-the-counter in Europe.

The European Medicines Agency said it had recommended the switch from prescription-only to nonprescription for a 60-milligram dose of alli, the same dose approved for sale OTC in the United States. The European Commission now needs to rubber-stamp the recommendation.

The European Medicines Agency said it had recommended the switch from prescription-only to nonprescription for a 60-milligram dose of alli, the same dose approved for sale OTC in the United States. The European Commission now needs to rubber-stamp the recommendation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Matrixx reports growth for Q2; strength in cold remedies market

BY Michael Johnsen

SCOTTSDALE, Ariz. Matrixx Initiatives on Wednesday reported an 18 percent increase of revenue to $33.6 million for its second quarter ending Sept. 30.

“We are pleased to report increased sales and income for the second quarter of fiscal 2009,” stated Bill Hemelt, acting president and chief operating officer for Matrixx. “Our growth has historically been from Zicam brand growth and the introduction of new and enhanced Zicam products,” he said, pointing to the company’s introduction of five new SKUs that are expected to help fuel growth in the coming cough/cold season.

The five new Zicam products include Cold Remedy RapidMelts + Vitamin C and Echinacea, Allergy Swabs, Cold Sore Swabs and Z-ssentials in orange and lemon-lime flavors.

Matrixx also achieved a new milestone and expanded across the U.S. border by introducing four Zicam products to the Canadian market. “We anticipate introducing several additional Zicam products—Congestion Relief, Sinus Relief, and Multi-Symptom—in Canada during the current quarter ending December 31,” Hemelt said.

“We are now focused on executing our marketing campaign for the upcoming cold season,” Hemelt said. “The Rhino campaign will be expanded to include television advertising, off-shelf display support, lifestyle placement at resorts and on airlines, as well as a ‘Save the Rhino not the Rhinovirus’ promotion with noted zoologist, Jack Hanna. We expect the marketing campaign will increase awareness and consumption of Zicam products by consumers who can’t afford to be sick,” he said.

Matrixx is expected to be less impacted by the confusion surrounding pediatric cough/cold formulations this year—the company does not field any products marketed toward children, either across its allopathic cough-cold symptom relieving remedies or its homeopathic zinc gluconate offerings.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Report shows consumer confidence in supplements on the rise

BY Michael Johnsen

WASHINGTON Consumer confidence in dietary supplements has remained high this year, with 81 percent of American adults indicating that they are confident in the safety, quality and effectiveness of dietary supplements compared to 80 percent last year, according to a new survey conducted by Ipsos-Public Affairs for the Council for Responsible Nutrition released Wednesday.

Confidence levels in dietary supplements have been on a gradual rise, with 79 percent of American adults indicating a favorable level of confidence in dietary supplements in 2006. 

According to the results from the 2008 CRN Consumer Survey on Dietary Supplements, while confidence in dietary supplements remains steady, the on-line survey showed a slightly lower percentage of adults who label themselves as supplement users, with 64 percent classifying themselves as such.  In 2007 and 2006, 68 percent and 66 percent of Americans identified themselves as supplement users, respectively. 

The survey results also demonstrated a rise in the percentage of supplement consumers who take a variety of supplements regularly—48 percent in 2008, versus 42 percent in 2007 and 34 percent in 2006.

“We’re encouraged both that consumers who take supplements are demonstrating an interest in a wider variety of products and are more committed to a supplement regimen,” Judy Blatman, senior vice president of communications for CRN, said. “The multivitamin remains the cornerstone product for our industry with 82 percent of supplement users taking a multivitamin, but consumers are clearly looking at the benefits of other products too, like fish oil supplements and calcium.”

As many as 85 percent of those surveyed further indicated that they believe vitamin and mineral supplements are safe, the same figure that was reported in 2007; similarly, 72 percent agreed that herbal supplements are safe, with 70 percent reporting that belief last year. 

“The self-regulatory programs that this industry is engaging in, along with emerging science that supports the value of supplements, are vital to the industry’s reputation, and to consumer confidence,” stated Steve Mister, president and chief executive officer, CRN.  “We’re gratified to see that consumer confidence in our industry’s products continues to remain strong.”

The 2008 CRN Consumer Survey on Dietary Supplements was conducted Aug. 20 through 25 by Ipsos Public Affairs and funded by CRN. The survey was conducted online and included a national sample of 2,013 adults aged 18 and older from Ipsos’ U.S. online panel. The survey has been conducted annually since 2000, with a migration from telephone to the internet beginning in 2005. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?